Renin-angiotensin-aldosterone system in brain infarction and vascular death

Annals of Neurology

Volumn 58, Issue 1, 2005, Pages 131-138

  Brenner, David ^a   Labreuche, Julien ^a   Poirier, Odette ^b   Cambien, François ^b   Amarenco, Pierre ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; ATHEROTHROMBOTIC STROKE; BRAIN INFARCTION; CARDIOEMBOLIC STROKE; CAUCASIAN; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; STROKE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALDOSTERONE SYNTHASE; ANGIOTENSINOGEN; BRAIN INFARCTION; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 21844436004     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20537     Document Type: Article

References (31)

1. Reid I. The renin-angiotensin system: physiology, pathophysiology, and pharmacology. Adv Physiol Educ 1998;20:S236-S245.
2. Gorelick P. New horizons for stroke prevention: PROGRESS and HOPE. Lancet Neurol 2002;1:149-156.
3. Weber KT. Aldosterone in congestive heart failure. N Engl J Med 2001;345:1689-1697,
4. The Heart Outcome Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153.
5. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
6. Touboul P, Elbaz A, Cornelia K, et al. Common carotid artery intima-media thickness and brain infarction. Circulation 2000;102:313-318.
7. Rubattu S, Di Angelantonio E, Stanzione R, et al. Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. Hypertension 2004;22:2129-2134.
8. Sethi AG, Tybjaerg-Hansen A, Gronholdt ML, et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 2001;134:941-954.
9. Cambien F, Costerousse O, Tiret L, et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-676.
10. Bonithon-Kopp C, Ducimetiere P, Touboul P, et al. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation 1994;89:952-954.
11. Ribichini F, Ferrero V, Matullo G, et al. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis. Clin Sci 2004;107:381-389.
12. Nagi D, Foy C, Mohamed-Ali V, et al. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism 1998;47:622-626.
13. Sassano P, Chatellier G, Billaud E, et al. Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor Enalapril. Am J Med 1988;83:227-235.
14. Larochelle P, Genest J, Juchel O, et al. Effect of Captopril on blood pressure, plasma renin activity and angiotensin I. Can Med Assoc J 1979;121:309-316.
15. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
16. Paillard F, Chansei D, Brand E, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999;34:423-42s9.
17. Takami S, Imai Y, Katsuya T, et al. Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction. The Ohasama study. Am J Hypertens 2000;13:121-127.
18. Canavy I, Henry M, Morange P, et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 2000;83:212-216.
19. Benetos A, Gautier S, Ricard S, et al. Influence of angiotensin- converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996;94:698-703.
20. Hindorff L, Heckbert S, Tracy R, et al. Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens 2002;15:1050-1056.
21. Reich H, Duncan J, Weinstein J, et al. Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney Int 2003;63:1443-1449.
22. Henskens L, Spiering W, Stoffers H, et al. Effects of the ACE I/D and AT1R polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocrates study. J Hypertens 2003;21:81-86.
23. Lajemi M, Labat C, Gautier S, et al. Angiotensin II type 1 receptor 153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001;19:407-413.
24. Rubattu S, Di Angelantonio E, Stanzione R, et al. Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant. J Hypertens 2004;22:2129-2134.
25. Takashima Y, Kokaze A, Matsunaga N, et al. Relations of blood pressure to angiotensinogen gene T174M polymorphism and alcohol intake. J Physiol Anthropol Appl Human Sci 2003;22:187-194.
26. Agachan B, Isbir T, Yilmaz H, Akoglu E. Angiotensin converting enzyme I/D, angiotensin T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med 2003;35:545-549.
27. Sehti A, Tybjaerg-Hansen A, Gronholdt M, et al. Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study. Ann Intern Med 2001;134:941-954.
28. Tiret L, Blanc H, Ruidavents J, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. J Hypertens 1998;16:37-44.
29. Jeunemaitre X, Soubrier F, Koteletsev Y, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.
30. Katsuya T, Koike G, Yee T, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345:1600-1603.
31. Nakata T, Kutsuya T, Rakugi H, et al. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Hypertension 1997;10:1391-1395.